Nine-gene pharmacogenomics profile service: The Mayo Clinic experience
The Pharmacogenomics Journal, Published online: 20 October 2021; doi:10.1038/s41397-021-00258-0Nine-gene pharmacogenomics profile service: The Mayo Clinic experience (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 20, 2021 Category: Drugs & Pharmacology Authors: Eric T. Matey Ashley Kate Ragan Lance J. Oyen Carolyn R. Vitek Stacy L. Aoudia Ahmed K. Ragab Kelliann C. Fee-Schroeder John L. Black Ann M. Moyer Wayne T. Nicholson Sofia Shrestha Tammy M. McAllister Jason P. Sinnwell Stephanie S. Faubion Konstantinos N. Source Type: research
Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers
The Pharmacogenomics Journal, Published online: 12 October 2021; doi:10.1038/s41397-021-00257-1Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 12, 2021 Category: Drugs & Pharmacology Authors: Leonardo A. Guerra Christelle Lteif Meghan J. Arwood Caitrin W. McDonough Leanne Dumeny Ankit A. Desai Larisa H. Cavallari Julio D. Duarte Source Type: research
A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin
The Pharmacogenomics Journal, Published online: 06 October 2021; doi:10.1038/s41397-021-00256-2A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 6, 2021 Category: Drugs & Pharmacology Authors: Negin Soroush Albert-Jan Aarnoudse Maryam Kavousi Jan A. Kors M. Arfan Ikram Christopher Newton-Cheh Fariba Ahmadizar Bruno H. Stricker Source Type: research
Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals
The Pharmacogenomics Journal, Published online: 09 September 2021; doi:10.1038/s41397-021-00254-4Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 9, 2021 Category: Drugs & Pharmacology Authors: Camila de Almeida Velozo Tailah Bernardo de Almeida Marcelo Costa Velho Mendes de Azevedo Isabela Espasandin Jorge Francisco da Cunha Pinto Sheila L ópez Luciana Pizzatti Amilcar Tanuri Sabrina da Silva Santos Marcelo Ribeiro-Alves Cynthia Chester Cardos Source Type: research
Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests
The Pharmacogenomics Journal, Published online: 03 September 2021; doi:10.1038/s41397-021-00253-5Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 3, 2021 Category: Drugs & Pharmacology Authors: Guang-dan Zhu Penn Whitley Leah LaRue Brandon Adkins Eric Dawson Angela Huskey Edmund V. Capparelli Andria L. Del Tredici Source Type: research
Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors
The Pharmacogenomics Journal, Published online: 26 August 2021; doi:10.1038/s41397-021-00252-6Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - August 26, 2021 Category: Drugs & Pharmacology Authors: A. Shalmiev G. Nadeau M. Aaron E. Ouimet-Grennan S. Drouin L. Bertout P. Beaulieu P. St-Onge L.-N. Veilleux F. Rauch A. Rezgui K. Petrykey C. Laverdi ère D. Sinnett N. Alos M. Krajinovic Source Type: research
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial
The Pharmacogenomics Journal, Published online: 11 August 2021; doi:10.1038/s41397-021-00250-8Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - August 11, 2021 Category: Drugs & Pharmacology Authors: Joseph P. Schacht Michaela Hoffman Brian H. Chen Raymond F. Anton Source Type: research
Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application
The Pharmacogenomics Journal, Published online: 10 August 2021; doi:10.1038/s41397-021-00248-2Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - August 10, 2021 Category: Drugs & Pharmacology Authors: Brittany A. Borden Ellie H. Jhun Keith Danahey Emily Schierer Jeffrey L. Apfelbaum Magdalena Anitescu Randall Knoebel Sajid Shahul Tien M. Truong Mark J. Ratain Peter H. O ’Donnell Source Type: research
AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients
The Pharmacogenomics Journal, Published online: 23 July 2021; doi:10.1038/s41397-021-00238-4AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - July 23, 2021 Category: Drugs & Pharmacology Authors: Anna Wajda Ewa Walczuk Barbara Stypi ńska Jakub Lach Danat Yermakovich Larysa Sivitskaya Katarzyna Romanowska-Pr óchnicka Tomasz Wysocki Ma łgorzata Jarończyk Agnieszka Paradowska-Gorycka Source Type: research
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19
The Pharmacogenomics Journal, Published online: 23 July 2021; doi:10.1038/s41397-021-00242-8G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19 (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - July 23, 2021 Category: Drugs & Pharmacology Authors: Jorge E. B. da Rocha Houcemeddine Othman Caroline T. Tiemessen Gerrit Botha Mich èle Ramsay Collen Masimirembwa Clement Adebamowo Ananyo Choudhury Jean-Tristan Brandenburg Mogomotsi Matshaba Gustave Simo Francisco-Javier Gamo Scott Hazelhurst Jorge E. B. Source Type: research
Economic evaluation in psychiatric pharmacogenomics: a systematic review
The Pharmacogenomics Journal, Published online: 02 July 2021; doi:10.1038/s41397-021-00249-1Economic evaluation in psychiatric pharmacogenomics: a systematic review (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - July 2, 2021 Category: Drugs & Pharmacology Authors: Kariofyllis Karamperis Maria Koromina Panagiotis Papantoniou Maria Skokou Filippos Kanellakis Konstantinos Mitropoulos Athanassios Vozikis Daniel J. M üller George P. Patrinos Christina Mitropoulou Source Type: research
Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis
The Pharmacogenomics Journal, Published online: 26 June 2021; doi:10.1038/s41397-021-00247-3Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 26, 2021 Category: Drugs & Pharmacology Authors: Chonlaphat Sukasem Suthida Sririttha Chonlawat Chaichan Thapanat Nakkrut Patompong Satapornpong Kanoot Jaruthamsophon Thawinee Jantararoungtong Napatrupron Koomdee Sadeep Medhasi Sarawut Oo-Puthinan Ticha Rerkpattanapipat Jettanong Klaewsongkram Pawinee R Source Type: research
New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
The Pharmacogenomics Journal, Published online: 22 June 2021; doi:10.1038/s41397-021-00245-5New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 22, 2021 Category: Drugs & Pharmacology Authors: Xiaomin Liu Hanshi Xu Huaiqian Xu Qingshan Geng Wai-Ho Mak Fei Ling Zheng Su Fang Yang Tao Zhang Jiyan Chen Huanming Yang Jian Wang Xiuqing Zhang Xun Xu Huijue Jia Zhiwei Zhang Xiao Liu Shilong Zhong Source Type: research
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection
The Pharmacogenomics Journal, Published online: 21 June 2021; doi:10.1038/s41397-021-00246-4Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 21, 2021 Category: Drugs & Pharmacology Authors: Arzu Cakir Melisa Tuncer Hilal Taymaz-Nikerel Ozlem Ulucan Source Type: research
Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes
The Pharmacogenomics Journal, Published online: 18 June 2021; doi:10.1038/s41397-021-00241-9Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 18, 2021 Category: Drugs & Pharmacology Authors: Katerina Grafanaki Ilias Skeparnias Christos K. Kontos Dimitrios Anastasakis Aigli Korfiati George Kyriakopoulos Konstantinos Theofilatos Seferina Mavroudi George Magoulas Dionissios Papaioannou Andreas Scorilas Constantinos Stathopoulos Denis Drainas Source Type: research
